Sign in

    Michael Atanacio

    Managing Director and Senior Equity Research Analyst at TD Cowen

    Michael Atanacio is a Managing Director and Senior Equity Research Analyst at TD Cowen, specializing in life science tools and diagnostics. He provides comprehensive coverage of companies such as Thermo Fisher Scientific, Illumina, Agilent Technologies, Waters Corporation, and Danaher, and has been recognized for a consistently high success rate and strong average returns with rankings cited by investment platforms like TipRanks. Atanacio began his Wall Street career after obtaining a degree in biochemistry, previously working at Oppenheimer & Co. before joining Cowen in 2017, and has developed a reputation for insightful stock calls and industry expertise. He holds active FINRA Series 7, 63, 86, and 87 registrations and is noted for his sharp analytical skills and leadership within the research team.

    Michael Atanacio's questions to Symbotic (SYM) leadership

    Michael Atanacio's questions to Symbotic (SYM) leadership • Q4 2024

    Question

    Michael Atanacio asked about the sizing of the Symbotic system content within the announced GreenBox facility and how the revenue and margin opportunity for GreenBox compares to direct-to-customer sites.

    Answer

    CFO Carol Hibbard clarified that the reported $150 million for the GreenBox facility includes the entire warehouse, with the Symbotic system being one component, similar in size to an average system contract. She explained that Symbotic sells the system to GreenBox at a similar revenue and margin profile as it does to other customers, and then participates in the JV's results as a 35% partner.

    Ask Fintool Equity Research AI